Key facts
- Notable investors include Blue Future Holding, Vaxxinova Norway.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Blue Analytics
- ·The full record, as it builds
Funding rounds
No funding rounds for Blue Analytics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Blue Analytics
Developer of diagnostics, genomics, and related analytical services designed to support aquaculture health and traceability. The company offers PCR analysis, sequencing, water-filtration diagnostics, bacteriology, histopathology, genotyping, microsatellite analyses and tracing, together with consultancy and rapid sampling kit ordering, enabling fish farming operators to optimize production efficiency, reduce waste, and improve biological outcomes.
- Sector
- Healthcare
- HQ
- Bergen, Norway
- Founded
- 2020
- Employees
- 18
- Website
- blueanalytics.no/
- Ownership
- Privately Held (backing)
Blue Analytics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Blue Analytics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Blue Analytics in its N-PORT filings yet. We sweep new filings monthly.